Literature DB >> 22953126

Embryonal rhabdomyosarcoma in mastoid and middle ear in a 3-year-old girl: a rare case report.

Saman Vegari1, Alireza Hemati, Hosein Baybordi, Leila Davarimajd, Ghasem Chatrbahr.   

Abstract

Introduction. The most common sarcoma of childhood is rhabdomyosarcoma, approximately 35% of all paediatric rhabdomyosarcomas occur in the head and neck. Case Report. A 3-year-old girl referred to our clinic due to serosanguineous purulent discharge from her right ear. After paraclinical and pathologic evaluation it was diagnosed as embryonic rhabdomyosarcoma. Conclusions. In all children with mastoiditis, especially in young children, rhabdomyosarcoma should be considered as a differential diagnosis.

Entities:  

Year:  2012        PMID: 22953126      PMCID: PMC3420705          DOI: 10.1155/2012/871235

Source DB:  PubMed          Journal:  Case Rep Otolaryngol        ISSN: 2090-6773


1. Introduction

The most common sarcoma of childhood is rhabdomyosarcoma [1, 2], this tumor is the third most common neoplasm in childhood after neuroblastoma and nephroblastoma [3, 4]. Approximately 35% of all paediatric rhabdomyosarcomas occur in the head and neck [3, 5]. The most common site that involved by rhabdomyosarcoma is orbit (about one-third of cases). After that, in decreasing order, rhabdomyosarcoma affects oral cavity and pharynx (29%), the face and neck region (24%) [3], involvement of the ear and temporal bone with rhabdomyosarcoma is uncommon [6]. Pathologic subtypes of rhabdomyosarcoma include: embryonal, botryoid, alveolar, pleomorphic, spindle cell, and anaplastic variants [7]. The embryonal rhabdomyosarcoma includes about 60–70% of rhabdomyosarcoma cases [8, 9].

2. Case Presentation

A 3-year-old girl referred to our clinic due to serosanguineous purulent discharge from her right ear. She was treated with antibiotics for a 3-week period with attenuation in the amount of drainage. In physical examination, there was a polypoid, reddish and fragile mass that filled external ear canal in right side, facial nerve was intact, and there was fetor discharge from the ear canal. Biochemistry tests were normal. In computer tomography, soft tissue density was present in mastoid and middle ear. The mass involved external ear and projected from external auditory meatus. There was ragged erosion in mastoid air cells and external surface of mastoid bone (Figure 1). Therefore, first diagnosis was neoplastic change and rhabdomyosarcoma was most probably because of patient age, metastatic neuroblastoma, lymphoma and leukemia was in differential diagnosis. Patient admitted and biopsy were done from the mass, pathologist reported keratinizing squamous epithelium, granulation tissue and abscess formation. After 2-week radical mastoidectomy was done via postauricular. During surgery external auditory canal and mastoid was full of polypoid granulomatous tissue while tympanic membrane was intact without perforation. Two samples were prepared and sent to two different pathology laboratories, first pathologist reported granulation tissue and keratinizing squamous epithelium, while the second pathologist reported embryonal rhabdomyosarcoma (Figure 2). Then multiagent chemotherapy and radiotherapy were suggested to patient parents and they did not accept to keep on treatment.
Figure 1

The mass involved external ear and projected from external auditory meatus. There was ragged erosion in mastoid air cells and external surface of mastoid bone.

Figure 2

The cells show a combination of shapes but a spindle or elongated morphology is evident overall. Strap cells that look like primitive muscle cells that classically describe in rhabdomyosarcoma are seen in this pictures.

3. Discussion

Rhabdomyosarcomas may originate in any anatomical site, occurring predominantly in head and neck regions, orbits, skull base, nasal cavity, and nasopharynx, where there is little or no musculoskeletal tissue [2, 10]. In pediatric cases, about 30 to 40% occur in the head and neck regions [3, 5, 10]; the ear and the temporal bone are uncommon sites of involvement. Chao et al. reported 3 patients with temporal bone involvement out of 102 cases [6]. In 1966 Potter reported a 3-year-old male with bilateral otitis media and polypoid mass in right external ear canal. The patient was diagnosed as having rhabdomyosarcoma [11]. Kukwa et al. in 2011 reported an embryonal rhabdomyosarcoma of the larynx in a 33-year-old man. After unsuccessful chemotherapy, hemilaryngectomy was performed. In follow-up CT no signs of recurrence were found. Recently patient was recurrence free for 62 months [12]. In 2008, Khatami et al. reported a case of congenital rhabdomyosarcoma in one-day-newborn, presented with huge mass in right hand and palpable lymph node in submaxillary [13]. In the 1960s, fewer than one-third of children with rhabdomyosarcoma survived, but cure rates are now approximatly 70%, largely reflecting advances made by the Intergroup Rhabdomyosarcoma Study Committee (IRSC) [3].

4. Conclusions

In all children with mastoiditis, especially in young children, rhabdomyosarcoma should be considered as a differential diagnosis.
  8 in total

1.  Intrasellar rhabdomyosarcoma: case report.

Authors:  K Arita; K Sugiyama; A Tominaga; F Yamasaki
Journal:  Neurosurgery       Date:  2001-03       Impact factor: 4.654

2.  Laryngeal embryonal rhabdomyosarcoma in an adult - a case presentation in the eyes of geneticists and clinicians.

Authors:  Wojciech Kukwa; Piotr Wojtowicz; Beata Jagielska; Grzegorz Sobczyk; Andrzej Kukwa; Anna M Czarnecka
Journal:  BMC Cancer       Date:  2011-05-12       Impact factor: 4.430

3.  International variations in the incidence of childhood soft-tissue sarcomas.

Authors:  C A Stiller; D M Parkin
Journal:  Paediatr Perinat Epidemiol       Date:  1994-01       Impact factor: 3.980

4.  Treatment, outcomes, and prognostic factors of ear cancer.

Authors:  C K Chao; T S Sheen; W Y Shau; L L Ting; M M Hsu
Journal:  J Formos Med Assoc       Date:  1999-05       Impact factor: 3.282

5.  Embryonal rhabdomyosarcoma of the middle ear in children.

Authors:  G D Potter
Journal:  Cancer       Date:  1966-02       Impact factor: 6.860

Review 6.  Rhabdomyosarcomas in adults and children: an update.

Authors:  David M Parham; Dale A Ellison
Journal:  Arch Pathol Lab Med       Date:  2006-10       Impact factor: 5.534

Review 7.  A follow-up of rhabdomyosarcoma of the infratemporal fossa region in adults based on the magnetic resonance imaging findings: case reports.

Authors:  T K Goto; K Yoshiura; T Tanaka; S Kanda; S Ozeki; M Ohishi; I Kobayashi; K Matsuo
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-11

8.  Embryonal rhabdomyosarcoma of the temporal bone.

Authors:  Borlingegowda Viswanatha
Journal:  Ear Nose Throat J       Date:  2007-04       Impact factor: 1.697

  8 in total
  6 in total

1.  A Toddler with Rhabdomyosarcoma Presenting as Acute Otitis Media with Mastoid Abscess.

Authors:  Sze Yin Ng; Bee See Goh
Journal:  Chin Med J (Engl)       Date:  2016-05-20       Impact factor: 2.628

2.  A mistaken identity: rhabdomyosarcoma of the middle ear cleft misdiagnosed as chronic suppurative otitis media with temporal lobe abscess.

Authors:  Mamta Muranjan; Sunil Karande; Shefali Parikh; Shilpa Sankhe
Journal:  BMJ Case Rep       Date:  2014-09-19

3.  Embryonal Rhabdomyosarcoma of External Ear - A Rare Case Report.

Authors:  Ananth Nag Jakkula; Tarun Gogineni; Srikanth Damera; P S S Meghana Sri Ravali
Journal:  Ann Maxillofac Surg       Date:  2022-02-01

4.  Rhabdomyosarcoma in middle ear of an adult: a rare presentation.

Authors:  S Bhargava; M Grover; J Mehta; V Maheshwari
Journal:  J Surg Case Rep       Date:  2012-10-01

Review 5.  Surgical Interventions for Advanced Parameningeal Rhabdomyosarcoma of Children and Adolescents.

Authors:  Paul J Choi; Joe Iwanaga; R Shane Tubbs; Emre Yilmaz
Journal:  Cureus       Date:  2018-01-09

6.  Embryonal Rhabdomyosarcoma - A Mimicker of Squamosal Otitis Media.

Authors:  Ajay Bhandarkar; Architha Menon; Ranjini Kudva; Kailesh Pujary
Journal:  Iran J Otorhinolaryngol       Date:  2020-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.